# Government of India Type: Company Source: GetYourBrief — https://getyourbrief.com/entity/government-of-india Canonical HTML page: https://getyourbrief.com/entity/government-of-india ## Timeline - **2026-09-09**: Jefferies publishes 'India's New Industrial Revolution' — Jefferies releases the equity strategy report identifying six high-growth industrial sectors for India's next expansion. - **2026-09**: JP Nadda addresses WHO RC79 roundtable — Union Health Minister JP Nadda presented India's medical workforce expansion during the Ministerial Roundtable on Human Resources for Health at the WHO Regional Committee for South-East Asia in Dili, Timor-Leste. - **2026-07**: 105 space authorisations granted — Government grants 105 authorisations for private space activity by July 2026, signalling rising launch and satellite activity. - **2026-04**: 10 semiconductor projects approved — Government approves 10 semiconductor projects worth about ₹1.6 trillion, including two fabs and eight packaging/OSAT units. - **2026-03**: Private space investment reaches $618.5 million — Cumulative private investment in India's space sector hits $618.5 million by March 2026. - **2025-09**: Seat-expansion schemes extended — The Government of India extended schemes for increasing medical seats, targeting 10,000 additional postgraduate seats by 2028-29 with priority for underserved areas and shortage specialties. - **2023**: Indian Space Policy 2023 released — Framework issued for private participation across the space value chain, clarifying roles for startups and established players. - **2022**: India space economy valued at $8.4 billion — IN-SPACe benchmarks India's space economy at $8.4 billion, the base year for future growth targets. - **2020**: Space sector opened to private players — Government of India opens the space sector to private participation, ending the state monopoly and enabling private launch and satellite ventures. - **2014**: Baseline medical education capacity — India began its reported expansion from 387 medical colleges, 51,348 MBBS seats, and 31,185 postgraduate seats. ## Recent coverage (5 stories, network-wide) ### $618.5M Private Space Capital Fuels India's 6-Sector Startup Boom 2026-09-10 21:37:12 · Sector: startups · Sentiment: Positive · Impact: 6/10 · Sources: 5 With private space investment reaching $618.5 million, 105 authorisations granted, and companies like Skyroot, Pixxel, Agnikul and Digantara moving to execution, India's six-sector industrial push is opening a new frontier for founders and VCs in deeptech, manufacturing and infrastructure. Full story: https://getstartupbrief.com/story/india-industrial-revolution-startups-space ### Jefferies Sees India's $40-45B Space Economy Leading 6-Sector Growth Call 2026-09-10 21:36:01 · Sector: finance · Sentiment: Positive · Impact: 6/10 · Sources: 5 Jefferies' new equity strategy report frames India's next industrial cycle around six capital-intensive sectors. For investors, the call implies a thematic shift beyond IT services toward semiconductors, space, solar and data centre supply chains, backed by roughly $20 billion in triggered semiconductor investment. Full story: https://getfinancebrief.com/story/india-new-industrial-revolution-jefferies-markets ### India's 176.69% PG Seat Rise Targets Specialized Care Gaps by 2028 2026-09-09 03:53:26 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 3 India reported postgraduate medical seats rose 176.69% from 31,185 to 86,287 since 2014, and it is targeting 10,000 more by 2028-29 for shortage specialties. The announcement came at the WHO South-East Asia Regional Committee, where equity in specialized care was the core agenda for Universal Health Coverage. Full story: https://gethealthbrief.com/story/india-176-pg-seat-rise-health-specialized-care ### India Must Move Beyond Generics to Secure Global Health Supply Chains in 2026 2026-09-07 00:25:17 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2 Piyush Goyal's Bharat Health Global Expo 2026 speech frames Indian pharma as a reliability partner for global healthcare supply chains. For healthcare systems, rebuilding API/KSM capability and moving beyond generics could reduce drug shortage risks. Policy emphasis on indigenous production may shift where hospitals and payers source critical medicines. Full story: https://gethealthbrief.com/story/india-pharma-resilient-health-supply-chains-2026 ### 2026 Expo: India Must Lead in New Molecules and Biotech, Says Goyal 2026-09-07 00:25:08 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 2 For biotech and pharma professionals, Piyush Goyal's speech signals a policy pivot from generics to innovation. The minister explicitly called for leadership in R&D, new molecular entities, and biotechnology, while acknowledging past API/KSM losses. This may reshape funding and regulatory priorities for Indian drug developers. Full story: https://getbiobrief.com/story/india-pharma-rd-new-molecules-biotech-goyal-2026 --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.